|

Lung Cancer Biomarkers and Screening

RECRUITINGSponsored by NYU Langone Health
Actively Recruiting
SponsorNYU Langone Health
Started2000-05
Est. completion2030-05
Eligibility
Age50 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT00301119

Summary

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Eligibility

Age: 50 Years+Healthy volunteers accepted
DISEASE CHARACTERISTICS:

* Screening Cohort

  * At high- or low-risk for lung cancer
  * Smoking history ≥ 20 pack years\*

    * With or without workplace exposure to asbestos
* NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older
* Rule-Out Lung cancer group

  * Referred for evaluation of suspicious nodules with 1 of the following diagnoses:

    * Lung cancer
    * Nonmalignant nodules (control group)

PATIENT CHARACTERISTICS:

* Not pregnant
* No prior malignancy except nonmelanoma skin cancer

PRIOR CONCURRENT THERAPY:

* Not specified

Conditions2

CancerLung Cancer

Locations1 site

NYU Cancer Institute at New York University Medical Center
New York, New York, 10016
James J. Tsay, MD, MSc212-598-6351Jun-Chieh.Tsay@nyulangone.org

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.